Walleye Capital LLC Biocryst Pharmaceuticals Inc Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Walleye Capital LLC holds 259,382 shares of BCRX stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

259,382

Previous 208,825 24.21%

Holding current value

$1.96 Million

Previous $1.29 Million 52.79%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $324,070 - $439,340	50,557 Added 24.21%	259,382 $1.97 Million
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $599,151 - $985,045	145,073 Added 227.56%	208,825 $1.29 Million
Q1 2024 May 15, 2024	SELL	$4.89 - $7.65 $3.18 Million - $4.98 Million	-650,706 Reduced 91.08%	63,752 $323,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $18,958 - $25,773	3,807 Added 0.54%	714,458 $4.28 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $3.59 Million - $4.23 Million	534,472 Added 303.37%	710,651 $5.03 Million
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $1.16 Million - $1.47 Million	166,635 Added 1745.97%	176,179 $1.24 Million
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $4.73 Million - $7.06 Million	-595,989 Reduced 98.42%	9,544 $79,000
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $3.82 Million - $5.17 Million	364,119 Added 150.83%	605,533 $6.95 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $1.96 Million - $2.69 Million	181,816 Added 305.07%	241,414 $3.04 Million
Q2 2022 Aug 08, 2022	SELL	$7.89 - $17.88 $970,225 - $2.2 Million	-122,969 Reduced 67.36%	59,598 $631,000
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $2.11 Million - $3.61 Million	182,567 New	182,567 $2.97 Million
Q4 2021 Mar 03, 2022	SELL	$11.18 - $15.46 $459,844 - $635,885	-41,131 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $386,128 - $479,603	27,173 Added 194.68%	41,131 $591,000
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $132,601 - $240,635	13,958 New	13,958 $221,000
Q2 2020 Aug 14, 2020	SELL	$1.9 - $5.61 $297,363 - $878,004	-156,507 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.6 - $4.11 $85,051 - $218,475	53,157 Added 51.43%	156,507 $313,000
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $164,326 - $356,557	103,350 New	103,350 $357,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Biocryst Pharmaceuticals Inc Transaction History